首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1671837

抗菌藥物市場按藥物類別、活性頻譜、給藥途徑、應用、分銷管道和地區分類

Antibacterial Drugs Market, By Drug Class, By Spectrum of Activity, By Route of Administration, By Application, By Distribution Channel, By Geography

出版日期: 2025年02月06日 | 出版商:

Coherent Market Insights | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球抗生素市場規模估計為 469.1 億美元，預計到 2032 年將達到 647.4 億美元，2025 年至 2032 年的複合年成長率為 4.7%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	469.1億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	4.70％	2032 年價值預測	647.4億美元

圖。

抗生素，也稱為抗生素，是對抗細菌感染的藥物，透過殺死細菌或抑制細菌生長來發揮作用。它被廣泛用於治療多種感染疾病，包括肺炎、結核病、炭疽、梅毒、麻風病和李斯特菌病。預計感染疾病流行、製藥公司對抗生素研究的投資增加以及強大的開發新藥管道等因素將在預測期內推動市場成長。然而，政府對新抗生素核准和抗生素抗藥性發展的嚴格監管可能會在一定程度上抑制市場的成長。

市場動態：

在預計預測期內，細菌感染疾病盛行率增加、新產品推出和強大的藥物管道等關鍵因素將推動全球抗生素市場的發展。根據美國疾病管制與預防中心（CDC）統計，光是2020年，美國就有超過280萬例抗生素抗藥性感染，導致超過35,000人死亡。這對有效抗菌藥物產生了巨大的需求。此外，領先的公司也不斷注重研發，開發創新藥物。例如，2022年8月，輝瑞公司獲得美國FDA核准一種新的抗生素治療藥物Relibactam，用於治療複雜的尿道感染和腹腔內感染疾病。然而，有關新抗生素核准的嚴格規定以及抗生素抗藥性的日益發展等因素預計會抑制市場的成長。此外，專注於開發噬菌體療法等替代治療方法預計將在未來幾年提供有利可圖的機會。

本研究的主要特點

本報告對全球抗生素市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），假設 2025 年為基準年。

它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球抗菌藥物市場的主要企業。

研究涉及的主要企業包括輝瑞、雅培、默克、葛蘭素史克、禮來公司、百時美施貴寶公司、強生、賽諾菲、拜耳和諾華。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球抗菌藥物市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員將透過用於分析全球抗菌藥物市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 46.91 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.70%	2032 Value Projection:	USD 64.74 Bn

Antibacterial drugs, also known as antibiotics, are medicines that fight bacterial infections and work by either killing or inhibiting the growth of bacteria. They are widely used for the treatment of various infections such as pneumonia, tuberculosis, anthrax, syphilis, leprosy, and listeriosis. Factors such as growth in the prevalence of infectious diseases, increasing investment by pharmaceutical companies in antibiotic research, and strong pipeline of newly developed drugs are expected to drive the market growth during the forecast period. However, stringent government regulations for the approval of new antibiotics and antibiotic resistance development may restrain the market growth to a certain extent.

Market Dynamics:

Key factors, such as increasing prevalence of bacterial infections, new product launches, and strong pipeline drugs, are projected to drive the global antibacterial drugs market during the forecast period. As per Centers for Disease Control and Prevention (CDC), in 2020 alone over 2.8 million antibiotic-resistant infections occurred in the U.S. and more than 35,000 people died. This creates significant demand for effective antibacterial drugs. Furthermore, large players are continuously focusing on R&D to develop innovative drugs. For instance, in August 2022, Pfizer Inc. received USFDA approval for its new antibiotic treatment, relebactam, to treat complicated urinary tract and intra-abdominal infections. However, factors like stringent regulations for approval of new antibiotics and increasing antibiotic resistance development are anticipated to restrain the market growth. Moreover, focus on the development of alternative treatment methods like bacteriophage therapy is expected to present lucrative opportunities in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global antibacterial drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2025 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global antibacterial drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Abbott, Merck, GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb Company, Johnson & Johnson, Sanofi, Bayer, and Novartis

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global antibacterial drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibacterial drugs market

Market Segmentation

By Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Penicillins
- Cephalosporins
- Aminoglycosides
- Tetracyclines
- Macrolides
- Fluoroquinolones
- Sulfonamides
- Others
By Spectrum of Activity Insights (Revenue, USD Bn, 2020 - 2032)
- Broad-spectrum Antibiotics
- Narrow-spectrum Antibiotics
By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Topical
- Intravenous
- Other Routes
By Application Insights (Revenue, USD Bn, 2020 - 2032)
- Skin Infections
- Respiratory Infections
- Urinary Tract Infections
- Septicemia
- Ear Infections
- Gastrointestinal Infections
- Other Applications
By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Merck & Co., Inc.
- Abbott Laboratories
- Novartis International AG
- GlaxoSmithKline plc
- Sanofi
- Hoffmann-La Roche Ltd.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Astellas Pharma Inc.
- Johnson & Johnson
- Amgen Inc.
- Bayer AG
- Eli Lilly and Company
- AstraZeneca plc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Antibacterial Drugs Market, By Drug Class
- Global Antibacterial Drugs Market, By Spectrum of Activity
- Global Antibacterial Drugs Market, By Route of Administration
- Global Antibacterial Drugs Market, By Application
- Global Antibacterial Drugs Market, By Distribution Channel
- Global Antibacterial Drugs Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Antibacterial Drugs Market, By Drug Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Penicillins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cephalosporins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Aminoglycosides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Tetracyclines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Macrolides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fluoroquinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sulfonamides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Antibacterial Drugs Market, By Spectrum of Activity, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Broad-spectrum Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Narrow-spectrum Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Antibacterial Drugs Market, By Route of Administration 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Routes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Antibacterial Drugs Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Skin Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Septicemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ear Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gastrointestinal Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Antibacterial Drugs Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Antibacterial Drugs Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Spectrum of Activity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
Africa

10. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Abbott Laboratories
Novartis International AG
GlaxoSmithKline plc
Sanofi
Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Astellas Pharma Inc.
Johnson & Johnson
Amgen Inc.
Bayer AG
Eli Lilly and Company
AstraZeneca plc